WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Stock

$2.73-0.05 (-1.8%)
Updated Mar 24, 2023
ANEB Price
$2.73
Fair Value Price
N/A
Market Cap
$69.98M
52 Week Low
$1.77
52 Week High
$7.73
P/E
-6.2x
P/B
4.51x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$10.64M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.09
Operating Cash Flow
-$8M
Beta
0.63
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ANEB Overview

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, develops treatments for people suffering from acute cannabinoid intoxication and substance addiction. The Company's lead product candidate, ANEB-001, is a potent, small molecule cannabinoid receptor antagonist designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, TX.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANEB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ANEB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ANEB is good value based on its book value relative to its share price (4.51x), compared to the US Biotechnology industry average (4.89x)
P/B vs Industry Valuation
ANEB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ANEB due diligence checks available for Premium users.

Be the first to know about important ANEB news, forecast changes, insider trades & much more!

ANEB News

Valuation

ANEB fair value

Fair Value of ANEB stock based on Discounted Cash Flow (DCF)
Price
$2.73
Fair Value
$3.45
Undervalued by
20.82%
ANEB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ANEB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-6.2x
Industry
17.88x
Market
21.37x

ANEB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.51x
Industry
4.89x
ANEB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ANEB's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.8M
Profit Margin
0%
ANEB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$16.9M
Liabilities
$1.4M
Debt to equity
0.09
ANEB's short-term assets ($16.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANEB's short-term assets ($16.89M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANEB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.6M
Investing
$0.0
Financing
-$248.9k
ANEB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ANEB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ANEB$69.98M-1.80%-6.20x4.51x
INKT$68.16M0.00%-2.42x-169.85x
CRDF$67.91M-1.94%-1.71x0.64x
RZLT$72.18M+0.51%-1.85x0.51x
GRNA$72.29M-5.92%0.02x0.86x

Anebulo Pharmaceuticals Stock FAQ

What is Anebulo Pharmaceuticals's quote symbol?

NASDAQ: ANEB) Anebulo Pharmaceuticals trades on the NASDAQ under the ticker symbol ANEB. Anebulo Pharmaceuticals stock quotes can also be displayed as NASDAQ: ANEB.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.

What is the 52 week high and low for Anebulo Pharmaceuticals (NASDAQ: ANEB)?

(NASDAQ: ANEB) Anebulo Pharmaceuticals's 52-week high was $7.73, and its 52-week low was $1.77. It is currently -64.66% from its 52-week high and 54.24% from its 52-week low.

How much is Anebulo Pharmaceuticals stock worth today?

(NASDAQ: ANEB) Anebulo Pharmaceuticals currently has 25,633,217 outstanding shares. With Anebulo Pharmaceuticals stock trading at $2.73 per share, the total value of Anebulo Pharmaceuticals stock (market capitalization) is $69.98M.

Anebulo Pharmaceuticals stock was originally listed at a price of $7.10 in May 7, 2021. If you had invested in Anebulo Pharmaceuticals stock at $7.10, your return over the last 1 years would have been -61.55%, for an annualized return of -61.55% (not including any dividends or dividend reinvestments).

How much is Anebulo Pharmaceuticals's stock price per share?

(NASDAQ: ANEB) Anebulo Pharmaceuticals stock price per share is $2.73 today (as of Mar 24, 2023).

What is Anebulo Pharmaceuticals's Market Cap?

(NASDAQ: ANEB) Anebulo Pharmaceuticals's market cap is $69.98M, as of Mar 27, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Anebulo Pharmaceuticals's market cap is calculated by multiplying ANEB's current stock price of $2.73 by ANEB's total outstanding shares of 25,633,217.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.